Hawaii Medical Journal

Table of Contents

1. Clinical Research GLP-1 Drugs May Reach Only Half of Eligible Patients

   Hawaii Medical Journal Staff April 21, 2026

   pp. 1–6
2. Oncology KRAS Inhibitor Daraxonrasib Shows Promise in Pancreatic Cancer

   Hawaii Medical Journal Staff April 21, 2026

   pp. 7–14
3. Neuroscience Alzheimer's Anti-Amyloid Drugs: Review Sparks Debate

   Hawaii Medical Journal Staff April 20, 2026

   pp. 15–23
4. Clinical Research Buprenorphine vs Methadone: Prenatal Neurodevelopmental Risks

   Hawaii Medical Journal Staff April 19, 2026

   pp. 24–31
5. Oncology Revolution Medicines Raises $2B After Pancreatic Cancer Trial

   Hawaii Medical Journal Staff April 18, 2026

   pp. 32–35
6. Clinical Research Anxiety Disorders: Treatment Access & Innovation Gaps

   Hawaii Medical Journal Staff April 17, 2026

   pp. 36–44
7. Public Health What Increases Vaccine Uptake? New Meta-Analysis Findings

   Hawaii Medical Journal Staff April 16, 2026

   pp. 45–49
8. Clinical Research FDA Warns Drugmakers Over Missing Clinical Trial Results

   Hawaii Medical Journal Staff April 15, 2026

   pp. 50–57
9. Clinical Research FDA Pushes Clinical Trial Transparency in 2026

   Hawaii Medical Journal Staff April 14, 2026

   pp. 58–66
10. Oncology Pancreatic Cancer Pill Doubles Survival in New Trial

    Hawaii Medical Journal Staff April 14, 2026

    pp. 67–74
11. Editorials The Future of Preconception Health: Progress and Gaps

    Hawaii Medical Journal Staff April 13, 2026

    pp. 75–81
12. Clinical Research High-Dose Influenza Vaccine Benefits: Authors' Reply

    Hawaii Medical Journal Staff April 12, 2026

    pp. 82–87
13. Public Health FDA Seeks New Powers Over Drug Ads in 2026

    Michael O'Connor April 9, 2026

    pp. 88–95
14. Clinical Research FDA Backs Domestic Drug Production to Counter China

    Keala Nakamura April 8, 2026

    pp. 96–100
15. Clinical Research FDA Delay Forces Kezar Life Sciences to Close Its Doors

    Keala Nakamura April 7, 2026

    pp. 101–108
16. Clinical Research FDA Delays Force Kezar Life Sciences to Shut Down

    Keala Nakamura April 6, 2026

    pp. 109–117
17. Public Health Trump Pushes Drug Pricing Legislation in 2026

    Hawaii Medical Journal April 1, 2026

    pp. 118–126
18. Cardiology BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial

    James Liu March 31, 2026

    pp. 127–135
19. Oncology Merck Acquires Terns Pharmaceuticals for $6.7B in 2026

    James Liu March 30, 2026

    pp. 136–141
20. Clinical Research Sarepta Therapeutics Shares Surge on Rare Disease Drug Data

    Keala Nakamura March 30, 2026

    pp. 142–148